Carglumic acid
NDC 35573-459, Carglumic acid, tablet, for suspension, from Burel Pharmaceuticals, LLC.
- Product NDC
- 35573-459
- Status
- Listed
- Labeler
- Burel Pharmaceuticals, LLC
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213395
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/35573-459 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARGLUMIC ACID200 mg/1
Pharmacologic classes
Carbamoyl Phosphate Synthetase 1 Activator [EPC]; Carbamoyl Phosphate Synthetase 1 Activators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 35573-459-60 | 35573045960 | 60 TABLET, FOR SUSPENSION in 1 BOTTLE (35573-459-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2aee4281-402b-4cd6-9e6a-08945262e1a1
Use it
Look up 35573-459 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/35573-459 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 35573-459. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.